ABOUT.

Regulus aims to develop important, novel oligonucleotide therapeutics that are designed to inhibit dysregulated microRNA targets for the benefit of patients with genetically based orphan diseases. We are focused on orphan kidney diseases where microRNA genetic drivers are implicated and there are clear unmet medical needs with an initial focus on orphan kidney diseases, including Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Beyond genetic kidney disease, we are excited about the potential applications of oligonucleotide inhibitors of microRNA for additional genetically defined diseases.

Our technology is based on our position as exclusive licensee of IP provided by Alnylam and Ionis, two leaders in oligonucleotide-based therapeutics, along with our continued novel discoveries since inception.

Management Team.

Jay Hagan

Jay Hagan

President & Chief Executive Officer
Cris Calsada

Cris Calsada

Chief Financial Officer
Christopher Aker

Christopher Aker

Senior Vice President & General Counsel
Denis Drygin, Ph.D.

Denis Drygin, Ph.D.

Chief Scientific Officer
Moh Ahmadian, Ph.D.

Moh Ahmadian, Ph.D.

Vice President, Chemistry & Pharmaceutical Development
Brian K. Campion, Ph.D.

Brian K. Campion, Ph.D.

Vice President, Business Development
Edmund Lee, Ph.D.

Edmund Lee, Ph.D.

Executive Director of Biology
Firuz Shakoori

Firuz Shakoori

Head of CMC
Tate Owen, Ph.D.

Tate Owen, Ph.D.

Director, Drug Metabolism & Pharmacokinetics
Daniel Penksa

Daniel Penksa

Senior Director, Finance & Controller
Morgan Carlson, Ph.D.

Morgan Carlson, Ph.D.

Senior Director of Biology
Amin Kamel, Ph.D.

Amin Kamel, Ph.D.

Vice President, Drug Metabolism & Pharmacokinetics

Contact.

Principal Executive Offices

4224 Campus Point Court, Suite 210,
San Diego, CA 92121
1-888-REGULUS (734-8587)

Directions

From I-5, take the Genesee Avenue exit and head east. Turn left at the second traffic light onto Campus Point Drive then turn left at the stop sign onto Campus Point Court. The destination will be on your right.

"*" indicates required fields